This is a routine tax-withholding sale by an insider following equity vesting. The dollar amount is negligible relative to market cap. No trading action warranted; monitor for any larger insider sales or changes in beneficial ownership.
Price Chart
Executive Summary
Gaurav Shah, an officer and director of Rocket Pharmaceuticals, filed a Form 144 notice of intent to sell 2,728 shares of common stock, with an approximate market value of $9,836. The shares were acquired on May 11, 2026, through restricted stock vesting as compensation. This is a routine, small-dollar sale by an insider to cover tax obligations from equity vesting, with no material impact on the company's outlook.
Key Facts
- Insider Gaurav Shah (Officer and Director) filed Form 144 to sell 2,728 shares
- Estimated sale value: $9,836.08
- Shares acquired on May 11, 2026 via restricted stock vesting (compensation)
- Sale is to cover tax obligations from vested equity award distribution
- Company market cap is approximately $1 million (RCKTW)
Financial Impact
Approximately $9,836 — less than 1% of the company's market cap
Risk Factors
- Insider selling pattern could emerge if additional Form 144s are filed
- Low market cap and limited liquidity may amplify any selling pressure
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-003569 |
| Document: 0001959173-26-003569-index.html | 0001959173-26-003569 |
| Document: 0001959173-26-003569.txt | 0001959173-26-003569 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
May 13, 2026 20w ago | 144 | $0.0193 $0.0193 | · 0.00% | ▲ +0.61% | — |
May 7, 2026 21w ago | 8-K | $0.0193 $0.0193 | · 0.00% | ▼ −0.02% | — |
May 7, 2026 21w ago | 144 | $0.0193 $0.0193 | · 0.00% | ▼ −3.14% | — |
Apr 28, 2026 22w ago | 8-K | $0.0193 $0.0193 | · 0.00% | ▼ −5.46% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access